Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Dysraphism | 38 | 2025 | 279 | 9.410 |
Why?
|
| Meningomyelocele | 24 | 2026 | 275 | 4.300 |
Why?
|
| Neural Tube Defects | 8 | 2024 | 343 | 1.930 |
Why?
|
| Emigrants and Immigrants | 3 | 2023 | 169 | 1.780 |
Why?
|
| Transition to Adult Care | 6 | 2025 | 126 | 1.450 |
Why?
|
| Fetoscopy | 12 | 2026 | 480 | 1.220 |
Why?
|
| Prenatal Care | 4 | 2025 | 339 | 1.190 |
Why?
|
| Global Health | 7 | 2025 | 626 | 1.030 |
Why?
|
| Fecal Incontinence | 6 | 2024 | 74 | 0.990 |
Why?
|
| Neurosurgery | 4 | 2024 | 71 | 0.960 |
Why?
|
| Hydrocephalus | 7 | 2025 | 290 | 0.920 |
Why?
|
| Noncommunicable Diseases | 1 | 2025 | 21 | 0.890 |
Why?
|
| Social Determinants of Health | 3 | 2024 | 158 | 0.850 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2022 | 39 | 0.840 |
Why?
|
| Autistic Disorder | 3 | 2022 | 396 | 0.800 |
Why?
|
| Continuity of Patient Care | 1 | 2025 | 141 | 0.800 |
Why?
|
| Self-Management | 3 | 2022 | 113 | 0.800 |
Why?
|
| Hysterotomy | 8 | 2026 | 141 | 0.770 |
Why?
|
| Intermittent Urethral Catheterization | 2 | 2022 | 8 | 0.740 |
Why?
|
| Urinary Incontinence | 4 | 2024 | 69 | 0.660 |
Why?
|
| Pregnancy | 18 | 2026 | 7423 | 0.620 |
Why?
|
| Child | 33 | 2026 | 26159 | 0.590 |
Why?
|
| Registries | 9 | 2025 | 1603 | 0.580 |
Why?
|
| Biomedical Research | 1 | 2025 | 561 | 0.580 |
Why?
|
| Humans | 73 | 2026 | 130403 | 0.560 |
Why?
|
| Walking | 3 | 2025 | 214 | 0.550 |
Why?
|
| Language | 1 | 2019 | 216 | 0.510 |
Why?
|
| Telemedicine | 1 | 2023 | 511 | 0.480 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 444 | 0.480 |
Why?
|
| Female | 45 | 2026 | 70343 | 0.470 |
Why?
|
| Mothers | 1 | 2019 | 368 | 0.460 |
Why?
|
| Child, Preschool | 25 | 2026 | 14982 | 0.430 |
Why?
|
| Quality of Life | 5 | 2022 | 2070 | 0.430 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2026 | 176 | 0.430 |
Why?
|
| Adolescent | 29 | 2026 | 20731 | 0.430 |
Why?
|
| Down Syndrome | 3 | 2020 | 234 | 0.410 |
Why?
|
| Young Adult | 21 | 2025 | 9974 | 0.410 |
Why?
|
| Fetal Diseases | 3 | 2025 | 457 | 0.410 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2026 | 621 | 0.410 |
Why?
|
| Neurosurgical Procedures | 4 | 2024 | 326 | 0.390 |
Why?
|
| International Educational Exchange | 1 | 2012 | 16 | 0.360 |
Why?
|
| Chronic Disease | 5 | 2025 | 1231 | 0.350 |
Why?
|
| United States | 11 | 2025 | 11826 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 3 | 2025 | 1292 | 0.330 |
Why?
|
| Infant | 18 | 2026 | 13276 | 0.320 |
Why?
|
| Scoliosis | 2 | 2022 | 157 | 0.320 |
Why?
|
| Infant, Newborn | 18 | 2026 | 8525 | 0.310 |
Why?
|
| Longevity | 2 | 2023 | 177 | 0.310 |
Why?
|
| Motor Activity | 3 | 2021 | 499 | 0.300 |
Why?
|
| Urinary Bladder Diseases | 2 | 2021 | 28 | 0.300 |
Why?
|
| Diphosphonates | 1 | 2009 | 41 | 0.290 |
Why?
|
| Adult | 20 | 2025 | 31125 | 0.280 |
Why?
|
| Male | 32 | 2026 | 64486 | 0.280 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 57 | 0.280 |
Why?
|
| Retrospective Studies | 20 | 2026 | 17633 | 0.260 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2009 | 172 | 0.250 |
Why?
|
| Decision Making | 1 | 2012 | 687 | 0.250 |
Why?
|
| Career Choice | 2 | 2012 | 165 | 0.240 |
Why?
|
| Prevalence | 6 | 2026 | 2683 | 0.240 |
Why?
|
| Neuropsychological Tests | 3 | 2024 | 955 | 0.230 |
Why?
|
| Quality Improvement | 2 | 2023 | 698 | 0.230 |
Why?
|
| Mobility Limitation | 1 | 2025 | 34 | 0.230 |
Why?
|
| Pediatrics | 2 | 2013 | 1244 | 0.230 |
Why?
|
| Physicians | 1 | 2012 | 634 | 0.220 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2025 | 137 | 0.220 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2026 | 94 | 0.210 |
Why?
|
| Spinal Cord | 1 | 2026 | 261 | 0.210 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 83 | 0.210 |
Why?
|
| Laparotomy | 1 | 2024 | 138 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5204 | 0.200 |
Why?
|
| Patient Care Team | 2 | 2025 | 553 | 0.200 |
Why?
|
| Treatment Outcome | 13 | 2026 | 12852 | 0.200 |
Why?
|
| Folic Acid | 2 | 2022 | 271 | 0.190 |
Why?
|
| Gestational Age | 5 | 2026 | 1223 | 0.190 |
Why?
|
| Pandemics | 2 | 2021 | 1154 | 0.190 |
Why?
|
| Ventriculostomy | 2 | 2025 | 46 | 0.190 |
Why?
|
| Decompression, Surgical | 2 | 2024 | 89 | 0.190 |
Why?
|
| Emigration and Immigration | 1 | 2023 | 81 | 0.190 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2024 | 99 | 0.190 |
Why?
|
| Child Development | 1 | 2025 | 266 | 0.180 |
Why?
|
| Corpus Callosum | 1 | 2022 | 109 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2012 | 1211 | 0.180 |
Why?
|
| Urology | 1 | 2022 | 80 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 200 | 0.180 |
Why?
|
| Diseases in Twins | 1 | 2021 | 88 | 0.170 |
Why?
|
| Urinary Bladder | 2 | 2022 | 219 | 0.160 |
Why?
|
| Laser Coagulation | 1 | 2021 | 117 | 0.160 |
Why?
|
| Spina Bifida Cystica | 1 | 2020 | 35 | 0.160 |
Why?
|
| Neurosurgeons | 1 | 2020 | 13 | 0.160 |
Why?
|
| Neurogenic Bowel | 1 | 2020 | 5 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 220 | 0.160 |
Why?
|
| Ulcer | 1 | 2019 | 51 | 0.150 |
Why?
|
| Fetofetal Transfusion | 1 | 2021 | 206 | 0.140 |
Why?
|
| Movement Disorders | 1 | 2021 | 219 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2002 | 323 | 0.140 |
Why?
|
| Counseling | 1 | 2020 | 236 | 0.140 |
Why?
|
| Comprehensive Health Care | 1 | 2017 | 13 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2020 | 556 | 0.130 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 56 | 0.130 |
Why?
|
| Urination | 1 | 2017 | 24 | 0.130 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 145 | 0.130 |
Why?
|
| Prenatal Diagnosis | 4 | 2025 | 646 | 0.130 |
Why?
|
| Research | 1 | 2019 | 264 | 0.130 |
Why?
|
| Self Efficacy | 1 | 2017 | 203 | 0.120 |
Why?
|
| Personal Autonomy | 1 | 2017 | 206 | 0.120 |
Why?
|
| Skin | 1 | 2019 | 540 | 0.120 |
Why?
|
| Disease Management | 1 | 2020 | 559 | 0.120 |
Why?
|
| Endoscopy | 1 | 2017 | 270 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 397 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2019 | 557 | 0.110 |
Why?
|
| Obesity | 1 | 2025 | 2383 | 0.100 |
Why?
|
| Brain | 1 | 2026 | 3188 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 500 | 0.090 |
Why?
|
| Organ Size | 2 | 2024 | 423 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 680 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2012 | 394 | 0.080 |
Why?
|
| Language Development Disorders | 2 | 2009 | 177 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2013 | 323 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3105 | 0.070 |
Why?
|
| Fractures, Spontaneous | 1 | 2009 | 19 | 0.070 |
Why?
|
| Long-Term Care | 1 | 2009 | 69 | 0.070 |
Why?
|
| Matched-Pair Analysis | 1 | 2008 | 28 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 552 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 6773 | 0.070 |
Why?
|
| Body Height | 1 | 2009 | 196 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2025 | 994 | 0.060 |
Why?
|
| Health Status | 2 | 2012 | 367 | 0.060 |
Why?
|
| Age of Onset | 1 | 2008 | 599 | 0.060 |
Why?
|
| Bone Density | 1 | 2009 | 365 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 378 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3841 | 0.060 |
Why?
|
| Qatar | 1 | 2025 | 3 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2022 | 6447 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 645 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2009 | 3408 | 0.050 |
Why?
|
| Fetal Therapies | 1 | 2025 | 96 | 0.050 |
Why?
|
| Aged | 5 | 2022 | 20899 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1250 | 0.050 |
Why?
|
| Ampicillin Resistance | 1 | 2003 | 18 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1487 | 0.050 |
Why?
|
| Argentina | 1 | 2023 | 53 | 0.050 |
Why?
|
| Sweden | 1 | 2023 | 56 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3805 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 224 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2023 | 63 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 298 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2023 | 109 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 2002 | 82 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 112 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 71 | 0.050 |
Why?
|
| Middle Aged | 5 | 2022 | 28395 | 0.040 |
Why?
|
| Incidence | 2 | 2021 | 3346 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1413 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2002 | 161 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 4015 | 0.040 |
Why?
|
| Twins | 1 | 2021 | 70 | 0.040 |
Why?
|
| Fetal Movement | 1 | 2021 | 13 | 0.040 |
Why?
|
| Disease Progression | 1 | 2008 | 2203 | 0.040 |
Why?
|
| Clubfoot | 1 | 2021 | 21 | 0.040 |
Why?
|
| Risk Factors | 3 | 2021 | 10981 | 0.040 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2021 | 51 | 0.040 |
Why?
|
| Internet | 1 | 2024 | 418 | 0.040 |
Why?
|
| Encephalocele | 1 | 2021 | 64 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 258 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 2020 | 28 | 0.040 |
Why?
|
| Cause of Death | 1 | 2023 | 505 | 0.040 |
Why?
|
| Suppositories | 1 | 2020 | 3 | 0.040 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 191 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2003 | 322 | 0.040 |
Why?
|
| Developing Countries | 1 | 2002 | 302 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2020 | 37 | 0.040 |
Why?
|
| Enema | 1 | 2020 | 46 | 0.040 |
Why?
|
| Fetus | 1 | 2023 | 582 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2025 | 1682 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 731 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2002 | 406 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 141 | 0.040 |
Why?
|
| Health Education | 1 | 2020 | 226 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2019 | 228 | 0.030 |
Why?
|
| Urodynamics | 1 | 2017 | 34 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2017 | 41 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 204 | 0.030 |
Why?
|
| Africa | 1 | 2017 | 140 | 0.030 |
Why?
|
| Self Report | 1 | 2021 | 556 | 0.030 |
Why?
|
| Curriculum | 1 | 2023 | 784 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 441 | 0.030 |
Why?
|
| Premature Birth | 1 | 2021 | 421 | 0.030 |
Why?
|
| Age Factors | 1 | 2023 | 2835 | 0.030 |
Why?
|
| Community Health Services | 1 | 2017 | 87 | 0.030 |
Why?
|
| Comorbidity | 1 | 2022 | 1587 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 366 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 313 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 700 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 175 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2020 | 401 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2002 | 769 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 597 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2018 | 212 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 359 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 296 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2298 | 0.020 |
Why?
|
| Accreditation | 1 | 2013 | 87 | 0.020 |
Why?
|
| Epilepsy | 1 | 2020 | 872 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5084 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 238 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 2546 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3614 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1840 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 814 | 0.020 |
Why?
|
| Stanford-Binet Test | 1 | 2009 | 2 | 0.020 |
Why?
|
| Communication Disorders | 1 | 2009 | 7 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 37 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2009 | 101 | 0.020 |
Why?
|
| Head | 1 | 2009 | 111 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4901 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 1222 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 2098 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6183 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 938 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3410 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 429 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2012 | 812 | 0.010 |
Why?
|
| Cefotaxime | 1 | 2003 | 37 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1893 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 33 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2002 | 12 | 0.010 |
Why?
|
| Gentamicins | 1 | 2003 | 86 | 0.010 |
Why?
|
| Utah | 1 | 2002 | 83 | 0.010 |
Why?
|
| Meningitis | 1 | 2003 | 98 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2003 | 74 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 95 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 177 | 0.010 |
Why?
|
| Seasons | 1 | 2002 | 333 | 0.010 |
Why?
|
| Gastroenteritis | 1 | 2003 | 306 | 0.010 |
Why?
|
| Fever | 1 | 2003 | 306 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3030 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2003 | 392 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 838 | 0.010 |
Why?
|
| Bacteremia | 1 | 2003 | 425 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 2003 | 327 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 800 | 0.010 |
Why?
|